Figure 6. Downregulation of miR-200a confers tumorigenicity to WB cells in vivo.

(A) Subcutaneous tumors developed by WB-miR-NC or WB-anti-miR-200a for 40 days post inoculation (left). Pictures of collected subcutaneous tumors were taken (middle) and tumor weights are shown (right). (B) Representative images of H&E staining of xenografted tumors are shown (left, magnification×200; right, magnification×400).